mail
versión imprimible
 
 

2nd ARDS Drug Development Summit 2022

Evvnt Promotion / evvnt
-
13.07.2022 - 15.07.2022  Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 09:00 - 16:15
 
Temas de la conferencia
Acute Respiratory Distress Syndrome (ARDS) is a growing and concerning unmet medical need with no effective therapeutic, and a serious medical burden in a world with or without COVID-19. Bringing industry together to consolidate the last 18 months of clinical and translational data, the 2nd ARDS Drug Development Summit is the only translational conference for drug developers to leverage the large homogeneous populations of COVID ARDS.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Alistair Wheeler, Chief Medical Officer, BioMarck Pharmaceuticals, Alpha A. Fowler, Professor, Virginia University, Aurelia De Pauw, Senior Vice President - Clinical Programs and Medical Affairs, Tetra Bio-Pharma and more.
 

Información e inscripción:

https://go.evvnt.com/1034443-1?pid=4832
Ms. Jessica Durston
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2199.0 - USD 4297.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Center of ExcellenceAnästhesie in Entwicklungsländern e. V.Ärztekammer für WienHelix - Forschung & Beratung WiennewTreeAlumni Club Medizinische Universität WienSwiss Tropical and Public Health InstituteAMREF - African Medical and Research Foundation